MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $207,000 | -14.5% | 7,500 | 0.0% | 0.04% | -22.6% |
| Q3 2021 | $242,000 | -16.8% | 7,500 | -21.1% | 0.05% | -23.2% |
| Q2 2021 | $291,000 | +0.7% | 9,500 | 0.0% | 0.07% | -30.3% |
| Q1 2021 | $289,000 | +11.6% | 9,500 | 0.0% | 0.10% | -5.7% |
| Q4 2019 | $259,000 | -4.8% | 9,500 | 0.0% | 0.10% | -8.7% |
| Q3 2019 | $272,000 | +30.8% | 9,500 | +26.7% | 0.12% | +29.2% |
| Q2 2019 | $208,000 | -16.5% | 7,500 | 0.0% | 0.09% | -16.8% |
| Q1 2019 | $249,000 | +14.2% | 7,500 | 0.0% | 0.11% | +3.9% |
| Q4 2018 | $218,000 | -5.2% | 7,500 | +50.0% | 0.10% | +12.0% |
| Q3 2018 | $230,000 | +6.5% | 5,000 | 0.0% | 0.09% | +9.5% |
| Q4 2015 | $216,000 | – | 5,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |